Petter Höglund
Om mig
KI:s akademiska val 2026 - kandidat till uppdraget som dekan för forskning
Jag är glad att vara en av kandiaterna till uppdraget som dekan för forskning vid KI! Nedan svarar jag på tre korta frågor som är relevanta för uppdraget, och efter det finns en lite längre motivering till varför jag vill bli dekan för forskning.
Vad motiverar mig att kandidera till uppdraget?
KI:s nya organisation har utmanat den kollegiala styrning som varit en avgörande del av vår utveckling. De initiativ som tagits för att stärka den är mycket bra och jag vill som dekan ta ansvar för att den utpekade riktningen upprätthålls och utvecklas. Jag vill också bidra med ett ökat fokus på förutsättningarna för både experimentell och klinisk forskning, och tror att min bakgrund och mina erfarenheter inom båda områdena är av värde för detta.
Vilka frågor eller områden vill jag prioritera under min mandatperiod?
Kommittén för forskning har med sin förankring i kollegiet både bredd och mandat att axla övergripande frågor inom KI, och behöver visa att man vill vara engagerad i alla frågor som påverkar våra förutsättningar för forskning, såsom resursfördelning, infrastrukturer, dimensionering, strategiska rekryteringar och ekonomiska förutsättningar för våra forskargrupper. Ett viktigt område är samverkan mellan våra experimentella forskningsmiljöer och ett annat är samarbetsklimatet med Region Stockholm. Djurverksamhet, biobanker, förutsättningar för preklinisk forskning och kliniska forskares behov av vetenskapliga interaktionsytor i sjukvårdens miljö är andra frågor jag vill prioritera.
Hur vill jag arbeta för att skapa samarbete och delaktighet inom KI?
Kommittén för forskning och dess dekan behöver bli mer synlig på KI och tydligt visa att de avser att ta ett övergripande ansvar. Regelbundna besök av dekan vid institutionsgruppernas möten är viktiga, liksom specifik dialog med prefekter om aktuella utmaningar. En självklarhet är intensiv samverkan med dekanerna för utbildning och forskarutbildning för att se till att KI:s hela uppdrag utvecklas i samverkan.
Motivering till varför jag vill bli dekan:
Som dekan för forskning vill jag bidra till att den kollegiala styrningen får större betydelse vid KI jämfört med idag. Kommittén for forskning har ett övergripande strategiskt uppdrag avseende KI:s forskning, vilket den är mycket lämpad för med sin bredd och erfarenhet från hela KI. Jag anser att kommittén tydligare än idag bör ta ledning i övergripande frågor som exempelvis resursallokering, forskningsinfrastrukturer, dimensionering av forskningsresurser, strategiska rekryteringar och lokaler/miljöer för forskning.
KI:s väg framåt ska präglas av öppenhet, samverkan och långsiktighet. Avgörande framåt är att vi fortsätter värna både grundforskning och klinisk forskning, och att vi säkerställer attraktiva miljöer för såväl etablerade forskare som forskare i den tidiga karriären. Lyhördhet för institutionernas delaktighet i allt förändringsarbete som påverkar forskningen måste genomsyra arbetet.
Forskningspropositionen har givit oss unika möjligheter. Kommittén måste vara djupt engagerad i dessa, där fokus ska ligga på kvalitet och excellens, underlättandet av tvärvetenskap, främjandet av samverkan och inspiration till byggande av långsiktiga forskningsmiljöer. Arbetet med dessa frågor ska understödjas av dekan och kommitté i nära dialog med fakultetsnämnd. Avgörande är också att vi fortsätter att investera i vår förmåga att lyckas i EU-systemet med strategiskt stöd, koordination och incitament. Här har kommittén för forskning en viktig roll.
Som dekan för forskning vill jag göra kommittén för forskning till en starkare kraft inom forskningsfrågor vid KI. Ökad närvaro i institutionsgrupperna är viktig, liksom direkt dialog med prefekter för diskussion om särskilda utmaningar och idéer. Med min långa erfarenhet av både experimentell och klinisk forskning vid KI anser jag mig ha goda förutsättning att axla ansvaret som dekan, och i den rollen fortsätta utveckla dialogen mellan KI och Region Stockholm och samtidigt agera på grundforskningens särskilda utmaningar. Självklart ser jag som en viktig del av uppdraget att samarbeta intensivt med dekanerna för KI:s två övriga kärnområden utbildning och forskarutbildning, och tillsammans med dem utveckla KI:s hela verksamhet på ett samlat sätt.
/Petter Höglund
Mer om mig:
Jag är forskargruppledare vid Institutionen för Medicin i Huddinge (MedH), där jag studerar immuntolerans och hur problem med denna process kan orsaka autoimmunitet och transfusionskomplikationer.
Jag har också ett långvarigt intresse för naturliga dödarceller (NK) och hur dessa utbildas. Min grupp studerar också trombocyternas funktion hos friska individer och hos patienter med metabola störningar och cancer, särskilt diabetes och leukemi.
Jag disputerade vid Karolinska Institutet 1993 och fullbordade min läkarutbildning 1996. Under min postdoc i Strasbourg, Frankrike arbetade jag med Diane Mathis och Christophe Benoist. Mitt projekt var att definiera tidiga immunologiska händelser vid autoimmun diabetes.
När jag återvände till Sverige 1999 etablerade jag min forskargrupp vid institutionen för mikrobiologi, tumörbiologi och cellbiologi (MTC), där jag blev docent 2003. 2011 rekryterades jag till MedH som professor i immunologi.
Jag blev specialist i klinisk immunologi och transfusionsmedicin 2016 och är sedan 2022 överläkare vid Karolinska universitetssjukhuset.
2019 utsågs jag till prefekt för MedH.
Artiklar
- Journal article: CYTOTHERAPY. 2025;27(5):s73-s74Tomaipitinca L; Lefsihane K; Gorgens A; Hoglund P; LeBlanc KL; Fiskesund R; Kadri N
- Article: HEMASPHERE. 2025;9(4):e70113Fioredda F; Spanoudakis M; Skokowa J; Tamary H; Farruggia P; Almeida A; Guardo D; Palmblad J; Hoeglund P; Touw IP; Zeidler C; Warren AJ; Csenar M; Skoetz N; Castagnola E; Ricci E; Dale DC; Newburger PE; Welte K; Papadaki HA; Dufour C
- Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2024;100(2):e13374Klove-Mogensen K; Steffensen R; Masmas TN; Glenthoj A; Jensen CF; Ratcliffe P; Hoglund P; Hasle H; Nielsen KR; Haunstrup TM
- Journal article: CYTOTHERAPY. 2024;26(6):e8Tomaipitinca L; Lefsihane K; Hald S; Cicortas B; Hoglund P; Kadri N; Fiskesund R
- Article: HLA. 2024;103(3):e15429Klove-Mogensen K; Haunstrup TM; Masmas TN; Glenthoj A; Hoglund P; Hasle H; Nielsen KR; Steffensen R
- Article: BLOOD ADVANCES. 2024;8(3):571-580Palmblad J; Sohlberg E; Nilsson CC; Lindqvist H; Deneberg S; Ratcliffe P; Meinke S; Mortberg A; Klimkowska M; Hoglund P
- Journal article: CLINICAL IMMUNOLOGY COMMUNICATIONS. 2023;3:31-36Kløve-Mogensen K; Steffensen R; Nielsen HL; Masmas TN; Glenthøj A; Jensen CF; Haunstrup TM; Ratcliffe P; Höglund P; Hasle H; Nielsen KR
- Article: TRANSFUSION. 2023;63(11):2040-2051Ryden J; Clements M; Wikman A; Hellstrom-Lindberg E; Edgren G; Hoglund P
- Article: SCIENCE SIGNALING. 2023;16(780):eabq0752Schmied L; Luu TT; Sondergaard JN; Hald SH; Meinke S; Mohammad DK; Singh SB; Mayer C; Casoni GP; Chrobok M; Schlums H; Rota G; Truong HM; Westerberg LS; Guarda G; Alici E; Wagner AK; Kadri N; Bryceson YT; Saeed MB; Hoglund P
- Article: HEMASPHERE. 2023;7(4):e872Fioredda F; Skokowa J; Tamary H; Spanoudakis M; Farruggia P; Almeida A; Guardo D; Hoglund P; Newburger PE; Palmblad J; Touw IP; Zeidler C; Warren AJ; Dale DC; Welte K; Dufour C; Papadaki HA
- Article: INTERNATIONAL JOURNAL OF IMMUNOGENETICS. 2023;50(2):65-74Klove-Mogensen K; Steffensen R; Masmas TN; Glenthoj A; Jensen CF; Haunstrup TM; Ratcliffe P; Hoglund P; Hasle H; Nielsen KR
- Article: FRONTIERS IN PUBLIC HEALTH. 2023;10:1073318Wikman A; Diedrich B; Bjorling K; Forsberg P-O; Harstad A-M; Henningsson R; Hoglund P; Skold H; ostman L; Sandgren P
- Article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2022;10(11):e005577Haroun-Izquierdo A; Vincenti M; Netskar H; van Ooijen H; Zhang B; Bendzick L; Kanaya M; Momayyezi P; Li S; Wiiger MT; Hoel HJ; Krokeide SZ; Kremer V; Tjonnfjord G; Berggren S; Wikstroem K; Blomberg P; Alici E; Felices M; oenfelt B; Hoeglund P; Valamehr B; Ljunggren H-G; Bjoerklund A; Hammer Q; Kveberg L; Cichocki F; Miller JS; Malmberg K-J; Sohlberg E
- Article: TRANSFUSION. 2022;62(8):1636-1642Klove-Mogensen K; Steffensen R; Masmas TN; Glenthoj A; Haunstrup TM; Ratcliffe P; Hoglund P; Hasle H; Nielsen KR
- Article: FRONTIERS IN IMMUNOLOGY. 2022;13:854312Luu TT; Sondergaard JN; Pena-Perez L; Kharazi S; Krstic A; Meinke S; Schmied L; Frengen N; Heshmati Y; Kierczak M; Bouderlique T; Wagner AK; Gustafsson C; Chambers BJ; Achour A; Kutter C; Hoglund P; Mansson R; Kadri N
- Article: BLOOD. 2022;139(5):704-716Sohlberg E; Pfefferle A; Ask EH; Tschan-Plessl A; Jacobs B; Netskar H; Lorenz S; Kanaya M; Kosugi-Kanaya M; Meinke S; Mortberg A; Hoglund P; Sundin M; Carlsson G; Palmblad J; Malmberg K-J
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;196(1):224-233Karlstrom C; Gryfelt G; Schmied L; Meinke S; Hoglund P
- Article: MALARIA JOURNAL. 2021;20(1):441Hedberg P; Sirel M; Moll K; Kiwuwa MS; Hoglund P; Ribacke U; Wahlgren M
- Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2021;94(1):e13037Mortberg A; Putsep K; Hoglund P
- Article: LIFE SCIENCE ALLIANCE. 2021;4(4):e202000723Luu TT; Schmied L; Nguyen N-A; Wiel C; Meinke S; Mohammad DK; Bergo M; Alici E; Kadri N; Ganesan S; Hoglund P
- Article: TRANSFUSION. 2021;61(4):1222-1234Mirlashari MR; Vetlesen A; Nissen-Meyer LSH; Naper C; Tjonnfjord GE; Njerve IU; Ezligini F; Landmark BF; Meinke S; Sandgren P; Hoglund P; Hetland G
- Article: TRANSFUSION. 2021;61(2):464-473Zhao J; Gabriel E; Norda R; Hoglund P; Baden L; Diedrich BA; Marits P; Enoksson SL; Gansner JM; Kaufman R; Dickman PW; Edgren G
- Journal article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2020;92(6):e12997Höglund P; Ljunggren H-G; Jonsson R
- Article: TRANSFUSION MEDICINE AND HEMOTHERAPY. 2020;47(5):385-395Flesch BK; Reil A; Nogues N; Canals C; Bugert P; Schulze TJ; Huiskes E; Porcelijn L; Hoglund P; Ratcliffe P; Schoenbacher M; Kerchrom H; Kellershohn J; Bayat B
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2020;50(4):494-504Luu TT; Wagner AK; Schmied L; Meinke S; Freund JE; Kambayashi T; Ravens I; Achour A; Bernhardt G; Chambers BJ; Hoglund P; Kadri N
- Article: FRONTIERS IN IMMUNOLOGY. 2019;10:2249Gavin C; Meinke S; Heldring N; Heck KA; Achour A; Iacobaeus E; Le Blanc K; Kadri N; Hoglund P
- Article: TRANSFUSION. 2019;59(3):945-952Karlstrom C; Linjama T; Edgren G; Lauronen J; Wikman A; Hoglund P
- Article: LEUKEMIA. 2019;33(2):522-527Ryden J; Edgren G; Karimi M; Walldin G; Tobiasson M; Wikman A; Hellstrom-Lindberg E; Hoglund P
- Article: FRONTIERS IN IMMUNOLOGY. 2019;9:3173Ganesan S; Hoglund P
- Journal article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2018;88(6):e12731Ljunggren H-G; Jonsson R; Höglund P
- Article: VOX SANGUINIS. 2018;113(8):779-786Wikman A; Jalkesten E; Ajne G; Hoeglund P; Mortberg A; Tiblad E
- Article: TRANSFUSION. 2018;58(11):2657-2668Meinke S; Wikman A; Gryfelt G; Hultenby K; Uhlin M; Hoeglund P; Sandgren P
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2018;183(2):212-224Palma M; Krstic A; Perez LP; Bergloef A; Meinke S; Wang Q; Blomberg KEM; Kamali-Moghaddam M; Shen Q; Jaremko G; Lundin J; De Paepe A; Hoeglund P; Kimby E; OEsterborg A; Mansson R; Smith CIE
- Article: THROMBOSIS RESEARCH. 2018;162:69-76Refsum E; Meinke S; Gryfelt G; Wikman A; Hoglund P
- Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(3):135-142Ganesan S; Luu TT; Chambers BJ; Meinke S; Brodin P; Vivier E; Wetzel DM; Koleske AJ; Kadri N; Hoglund P
- Article: NATURE COMMUNICATIONS. 2017;8(1):224Activated NK cells cause placental dysfunction and miscarriages in fetal alloimmune thrombocytopeniaYougbare I; Tai W-S; Zdravic D; Oswald BE; Lang S; Zhu G; Leong-Poi H; Qu D; Yu L; Dunk C; Zhang J; Sled JG; Lye SJ; Brkic J; Peng C; Hoglund P; Croy BA; Adamson SL; Wen X-Y; Stewart DJ; Freedman J; Ni H
- Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;85(6):417-424O'Flaherty SM; Sutummaporn K; Haggtoft WL; Worrall AP; Rizzo M; Braniste V; Hoglund P; Kadri N; Chambers BJ
- Article: NATURE COMMUNICATIONS. 2017;8:15627Wagner AK; Kadri N; Snall J; Brodin P; Gilfillan S; Colonna M; Bernhardt GN; Hoglund P; Karre K; Chambers BJ
- Journal article: ISBT SCIENCE SERIES. 2017;12(1):148-153Meinke S; Karlström C; Gryfelt G; Wikman A; Höglund P
- Article: TRANSFUSION MEDICINE. 2017;27(1):43-51Refsum E; Mortberg A; Dahl J; Meinke S; Auvinen M-K; Westgren M; Reilly M; Hoglund P; Wikman A
- Article: VOX SANGUINIS. 2017;112(1):33-39Gulliksson H; Meinke S; Ravizza A; Larsson L; Hoglund P
- Article: SCIENTIFIC REPORTS. 2016;6:37996Thuy TL; Ganesan S; Wagner AK; Sarhan D; Meinke S; Garbi N; Haemmerling G; Alici E; Karre K; Chambers BJ; Hoglund P; Kadri N
- Article: JOURNAL OF IMMUNOLOGICAL METHODS. 2016;434:9-15Mortberg A; Meinke S; Berg P; Killie MK; Kjeldsen-Kragh J; Jaras K; Refsum E; Hoglund P; Wikman A
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46(7):1758-1769Lakshmikanth T; Heuts F; Muvva SSVJR; Wallin RPA; Persson A-K; Fauriat C; Applequist SE; Ljunggren H-G; Hoglund P; Karre K; Svensson M; Juarez JG
- Article: CANCER IMMUNOLOGY RESEARCH. 2016;4(2):113-123Wagner AK; Wickstrom SL; Tallerico R; Salam S; Lakshmikanth T; Brauner H; Hoglund P; Carbone E; Johansson MH; Karre K
- Article: TRANSFUSION. 2016;56(2):370-369Meinke S; Sandgren P; Mortberg A; Karlstrom C; Kadri N; Wikman A; Hoglund P
- Article: IMMUNOLOGY AND CELL BIOLOGY. 2016;94(2):177-184Brauner H; Hall HT; Flodstrom-Tullberg M; Karre K; Hoglund P; Johansson S
- Article: TRANSFUSION. 2014;54(3):602-612Sandgren P; Meinke S; Eckert E; Douagi I; Wikman A; Hoglund P
- Article: BLOOD TRANSFUSION. 2013;11(3):456-459Hoglund P; Rosengren-Lindquist R; Wikman AT
- Article: FRONTIERS IN IMMUNOLOGY. 2013;4:65Sternberg-Simon M; Brodin P; Pickman Y; Onfelt B; Karre K; Malmberg K-J; Hoglund P; Mehr R
- Article: ACTA DERMATO-VENEREOLOGICA. 2012;92(6):609-614Ingvar A; Smedby KE; Lindelof B; Fernberg P; Bellocco R; Tufveson G; Hoglund P; Adami J
- Article: JOURNAL OF IMMUNOLOGY. 2012;188(5):2218-2226Brodin P; Lakshmikanth T; Karre K; Hoglund P
- Article: AMERICAN JOURNAL OF TRANSPLANTATION. 2011;11(11):2472-2482Fernberg P; Edgren G; Adami J; Ingvar A; Bellocco R; Tufveson G; Hoglund P; Kinch A; Simard JF; Baecklund E; Lindelof B; Pawitan Y; Smedby KE
- Article: BIOPHYSICAL JOURNAL. 2011;101(5):1257-1269Stromqvist J; Johansson S; Xu L; Ohsugi Y; Andersson K; Muto H; Kinjo M; Hoglund P; Widengren J
- Article: JOURNAL OF IMMUNOLOGY. 2011;187(2):760-773Kaplan A; Kotzer S; Almeida CR; Kohen R; Halpert G; Salmon-Divon M; Koehler K; Hoeglund P; Davis DM; Mehr R
- Article: PLOS ONE. 2010;5(10):e13174Brodin P; Lakshmikanth T; Mehr R; Johansson MH; Duru AD; Achour A; Salmon-Divon M; Karre K; Hoglund P; Johansson S
- Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(8):2764-2771Ingvar A; Smedby KE; Lindelof B; Fernberg P; Bellocco R; Tufveson G; Hoglund P; Adami J
- Article: JOURNAL OF IMMUNOLOGY. 2010;184(5):2272-2280Brauner H; Elemans M; Lemos S; Broberger C; Holmberg D; Flodstrom-Tullberg M; Karre K; Hoglund P
- Article: JOURNAL OF AUTOIMMUNITY. 2010;34(1):66-72Lindh E; Rosmaraki E; Berg L; Brauner H; Karlsson MCI; Peltonen L; Hoglund P; Winqvist O
- Article: PLOS ONE. 2009;4(6):e6046Johansson S; Salmon-Divon M; Johansson MH; Pickman Y; Brodin P; Karre K; Mehr R; Hoglund P
- Article: JOURNAL OF CLINICAL INVESTIGATION. 2009;119(5):1251-1263Lakshmikanth T; Burke S; Ali TH; Kimpfler S; Ursini F; Ruggeri L; Capanni M; Umansky V; Paschen A; Sucker A; Pende D; Groh V; Biassoni R; Hoglund P; Kato M; Shibuya K; Schadendorf D; Anichini A; Ferrone S; Velardi A; Karre K; Shibuya A; Carbone E; Colucci F
- Article: IMMUNITY. 2009;30(3):337-347Chalifour A; Scarpellino L; Back J; Brodin P; Devevre E; Gros F; Levy F; Leclercq G; Hoglund P; Beermann F; Held W
- Article: BLOOD. 2009;113(11):2434-2441Brodin P; Lakshmikanth T; Johansson S; Karre K; Hoglund P
- Article: JOURNAL OF IMMUNOLOGY. 2009;182(3):1460-1468Cheng M; Charoudeh HN; Brodin P; Tang Y; Lakshmikanth T; Hoglund P; Jacobsen SEW; Sitnicka E
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2008;38(11):2934-2937Brodin P; Hoglund P
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2008;38(11):3191-3199Hall HTL; Sjolin H; Brauner H; Tomasello E; Dalod M; Vivier E; Hoglund P
- Article: MOLECULAR IMMUNOLOGY. 2008;45(11):3059-3064Berglund JP; Mariotti-Ferrandiz E; Rosmaraki E; Hall H; Cazenave P-A; Six A; Hoglund P
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2007;37(2):516-527Andersson KE; Williams GS; Davis DM; Hoglund P
- Article: JOURNAL OF IMMUNOLOGY. 2006;177(5):2908-2916Sjolin H; Robbins SH; Bessou G; Hidmark A; Tomasello E; Johansson M; Hall H; Charifi F; Hedestam GBK; Biron CA; Karre K; Hoglund P; Vivier E; Dalod M
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2006;36(2):264-266Höglund P
- Article: JOURNAL OF IMMUNOLOGICAL METHODS. 2005;307(1-2):73-81Thorvaldson L; Johansson SE; Höglund P; Sandler S
- Article: JOURNAL OF EXPERIMENTAL MEDICINE. 2005;201(7):1145-1155Johansson S; Johansson M; Rosmaraki E; Vahlne G; Mehr R; Salmon-Divon M; Lemonnier F; Kärre K; Höglund P
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004;101(48):16873-16878Vanherberghen B; Andersson K; Carlin LM; Hoen ENMN; Williams GS; Höglund P; Davis DM
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2004;34(11):3091-3101Hall HTL; Petrovic J; Höglund P
- Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2004;60(1-2):134-142Petrovic J; Hall H; Mehr R; Glas R; Höglund P
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2004;34(6):1646-1653Öberg L; Johansson S; Michaëlsson J; Tomasello E; Vivier E; Kärre K; Höglund P
- Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2004;59(1):71-78Johansson MH; Höglund P
- Article: INTERNATIONAL IMMUNOLOGY. 2004;16(1):1-11Johansson SE; Hall H; Björklund J; Höglund P
- Article: IMMUNOLOGY. 2003;110(3):313-321Sköld M; Stenström M; Sidobre S; Höglund P; Kronenberg M; Cardell S
- Article: CANCER IMMUNITY. 2003;3:6Höglund P; Kärre K; Klein G
- Journal article: CLINICAL AND DEVELOPMENTAL IMMUNOLOGY. 2003;10(2-4):183-192Salmon-Divon M; Höglund P; Mehr R
- Article: BULLETIN OF MATHEMATICAL BIOLOGY. 2003;65(2):199-218Salmon-Divon M; Höglund P; Mehr R
- Article: JOURNAL OF EXPERIMENTAL MEDICINE. 2001;194(10):1519-1530Sjöström A; Eriksson M; Cerboni C; Johansson MH; Sentman CL; Kärre K; Höglund P
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2000;30(2):525-533Johansson MH; Bieberich C; Kåse-Sjöström A; Yoshioka T; Höglund E; Christy BA; Scangos G; Kärre K; Jay G; Höglund P
- Article: INTERNATIONAL IMMUNOLOGY. 1999;11(8):1239-1246Lindberg J; Martín-Fontecha A; Höglund P
- Article: JOURNAL OF EXPERIMENTAL MEDICINE. 1999;189(2):331-339Höglund P; Mintern J; Waltzinger C; Heath W; Benoist C; Mathis D
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1998;28(12):4198-4206Johansson MH; Höglund E; Nakamura MC; Ryan JC; Höglund P
- Article: JOURNAL OF IMMUNOLOGY. 1998;161(11):6133-6138Kåse A; Johansson MH; Olsson-Alheim MY; Kårre A; Höglund P
- Article: DIABETES. 1998;47(8):1207-1211Wang B; Gonzalez A; Höglund P; Katz JD; Benoist C; Mathis D
- Article: JOURNAL OF EXPERIMENTAL MEDICINE. 1998;187(3):427-432Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes.Lühder F; Höglund P; Allison JP; Benoist C; Mathis D
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1998;28(1):370-378Höglund P; Glas R; Ménard C; Kåse A; Johansson MH; Franksson L; Lemmonier F; Kärre K
- Article: JOURNAL OF EXPERIMENTAL MEDICINE. 1997;186(3):353-364Johansson MH; Bieberich C; Jay G; Karre K; Hoglund P
- Article: TRANSPLANTATION. 1997;63(1):119-123Torgersen KM; Salcedo M; Vaage JT; Naper C; Rolstad B; Ljunggren HG; Hoglund P
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1997;27(1):342-345Hoglund P; OlssonAlheim MY; Johansson M; Karre K; Sentman CL
- Article: CARCINOGENESIS. 1995;16(10):2515-2521KULKARNI PS; SUNDQVIST K; BETSHOLTZ C; HOGLUND P; WIMAN KG; ZHIVOTOVSKY B; BERTOLERO F; LIU Y; GRAFSTROM RC
- Article: TRANSPLANTATION. 1995;60(3):281-286SALCEDO M; HOGLUND P; LJUNGGREN HG
- Article: MOLECULAR IMMUNOLOGY. 1995;32(11):789-794SALCEDO M; HOGLUND P; ACHOUR A; THORPE CJ; LJUNGGREN HG
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1995;25(5):1286-1291OHLEN C; HOGLUND P; SENTMAN CL; CARBONE E; LJUNGGREN HG; KOLLER B; KARRE K
- Article: CANCER RESEARCH. 1995;55(9):1911-1916GLAS R; WALDENSTROM M; HOGLUND P; KLEIN G; KARRE K; LJUNGGREN HG
- Journal article: JOURNAL OF IMMUNOLOGY. 1994;153(12):5482-5490SENTMAN CL; OLSSON MY; SALCEDO M; HOGLUND P; LENDAHL U; KARRE K
- Journal article: JOURNAL OF EXPERIMENTAL MEDICINE. 1994;179(2):661-672GLAS R; OHLEN C; HOGLUND F; KARRE K
- Journal article: JOURNAL OF IMMUNOTHERAPY WITH EMPHASIS ON TUMOR IMMUNOLOGY : OFFICIAL JOURNAL OF THE SOCIETY FOR BIOLOGICAL THERAPY. 1993;14(3):175-181HOGLUND P; WALDENSTROM M; KARRE K
- Journal article: INTERNATIONAL JOURNAL OF CANCER. 1993;54(3):518-523ALGARRA I; PEREZ M; HOGLUND P; GAFORIO JJ; LJUNGGREN HG; GARRIDO F
- Journal article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1992;89(23):11381-11385GLAS R; FRANKSSON L; OHLEN C; HOGLUND P; KOLLER B; LJUNGGREN HG; KARRE K
- Journal article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1992;22(10):2697-2703STUBER G; MODROW S; HOGLUND P; FRANKSSON L; ELVIN J; WOLF H; KARRE K; KLEIN G
- Journal article: TRENDS IN IMMUNOLOGY. 1992;13(8):300-306MORETTA L; CICCONE E; MORETTA A; HOGLUND P; OHLEN C; KARRE K
- Journal article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1991;88(22):10332-10336HOGLUND P; OHLEN C; CARBONE E; FRANKSSON L; LJUNGGREN HG; LATOUR A; KOLLER B; KARRE K
- Journal article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1991;21(11):2767-2774AOSAI F; OHLEN C; LJUNGGREN HG; HOGLUND P; FRANKSSON L; PLOEGH H; TOWNSEND A; KARRE K; STAUSS HJ
- Journal article: JOURNAL OF EXPERIMENTAL MEDICINE. 1991;174(2):327-334HOGLUND P; GLAS R; OHLEN C; LJUNGGREN HG; KARRE K
- Journal article: INTERNATIONAL JOURNAL OF CANCER. SUPPLEMENT = JOURNAL INTERNATIONAL DU CANCER. SUPPLEMENT. 1991;6:38-44LJUNGGREN HG; OHLEN C; HOGLUND P; FRANKSSON L; KARRE K
- Journal article: NATURE. 1990;346(6283):476-480LJUNGGREN HG; STAM NJ; OHLEN C; NEEFJES JJ; HOGLUND P; HEEMELS MT; BASTIN J; SCHUMACHER TNM; TOWNSEND A; KARRE K; PLOEGH HL
- Journal article: IMMUNOLOGIC RESEARCH. 1990;9(4):298-313HOGLUND P; LJUNGGREN HG; KARRE K; JAY G
- Journal article: SCIENCE. 1989;246(4930):666-668OHLEN C; KLING G; HOGLUND P; HANSSON M; SCANGOS G; BIEBERICH C; JAY G; KARRE K
- Journal article: JOURNAL OF EXPERIMENTAL MEDICINE. 1988;168(4):1469-1474HOGLUND P; LJUNGGREN HG; OHLEN C; AHRLUND-RICHTER L; SCANGOS G; BIEBERICH C; JAY G; KLEIN G; KARRE K
- Journal article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 1988;80(4):263-269YAMASAKI T; KLEIN G; LJUNGGREN HG; HOGLUND P; OHLEN C; PETERSSON MGE; KARRE K
- Journal article: JOURNAL OF IMMUNOLOGY. 1988;140(2):671-678LJUNGGREN HG; OHLEN C; HOGLUND P; YAMASAKI T; KLEIN G; KARRE K
- Journal article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1987;84(10):3405-3409TANIGUCHI K; PETERSSON M; HOGLUND P; KIESSLING R; KLEIN G; KARRE K
- Visa fler
Alla övriga publikationer
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2024;99(1):e13347Hoglund P
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2023;98(6):e13340Buggert M; Hoglund P
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2023;97(6)Hoglund P
- Conference publication: HLA. 2023;101(4):369Klove-Mogensen K; Steffensen R; Masmas TN; Glenthoj A; Haunstrup TM; Ratcliffe P; Hoglund P; Hasle H; Nielsen KR
- Conference publication: HLA. 2023;101(4):368-369Klove-Mogensen K; Steffensen R; Masmas TN; Glenthoj A; Haunstrup TM; Ratcliffe P; Hoglund P; Hasle H; Nielsen KR
- Review: HEMASPHERE. 2023;7(1):e814Fioredda F; Dufour C; Hoglund P; Papadaki HA; Palmblad J
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;96(6)Hoglund P; Ljunggren H-G; Jonsson R
- Conference publication: BLOOD. 2022;140:5485-5486KlOve-Mogensen K; Steffensen R; Masmas TN; Hoglund P; Glenthoj A; Haunstrup T; Ratcliffe P; Hasle H; Nielsen KR
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;96(5)Hoglund P
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;96(3)Hoglund P
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;96(2)Hoglund P
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;96(1):e13199Hoglund P
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;95(6)Hoglund P
- Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2022;97(6):E207-E210Bergman P; Broliden P-A; Ratcliffe P; Lourda M; Flesch B; Hoglund P; Palmblad J
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;95(5):e13173Corthay A; Hoglund P
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;95(4):e13165Hoglund P
- Preprint: BIORXIV. 2022Schmied L; Luu T; Søndergaard J; Meinke S; Mohammad D; Singh S; Mayer C; Casoni G; Chrobok M; Schlums H; Rota G; Truong H; Westerberg L; Guarda G; Alici E; Wagner A; Kadri N; Bryceson Y; Saeed M; Höglund P
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;95(3):e13147Hoglund P
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;95(2):e13141Hoglund P
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;95(1):e13127Hoglund P
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2021;94(6)Luu T; Schmied L; Sondergaard JN; Saeed MB; Meinke S; Mohammad D; Casoni GP; Schlums H; Truong HM; Westerberg L; Bryceson Y; Alici E; Wagner AK; Kadri N; Hoglund P
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2021;94(6)Schmied L; Meinke S; Brandt L; Thanh TL; Karlstrom C; Sandgren P; Vidarsson G; Onfelt B; Hoglund P
- Letter: EUROPEAN JOURNAL OF IMMUNOLOGY. 2021;51(10):2531-2534Ganesan S; Hoglund P
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2021;94(1)Hoglund P
- Review: FRONTIERS IN IMMUNOLOGY. 2021;12:640578Schmied L; Hoglund P; Meinke S
- Preprint: BIORXIV. 2021Luu T; Søndergaard JN; Peña-Pérez L; Kharazi S; Krstic A; Meinke S; Schmied L; Frengen N; Heshmati Y; Kierczak M; Bouderlique T; Wagner AK; Gustafsson C; Chambers B; Achour A; Kutter C; Höglund P; Månsson R; Kadri N
- Conference publication: BLOOD. 2020;136:24-25Sohlberg E; Pfefferle A; Ask EH; Tschan-Plessl A; Jacobs B; Lorenz S; Meinke S; Hoglund P; Sundin M; Karlsson G; Palmblad J; Malmberg K-J
- Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(7):E163-E166Fragiadaki I; Papadakis S; Sevastaki G; Sfyridaki K; Mavroudi I; Goulielmos GN; Kanellou P; Mortberg A; Hoglund P; Gemenetzi K; Stamatopoulos K; Chatzidimitriou A; Palmblad J; Papadaki HA
- Editorial: HEMASPHERE. 2020;4(3):e406Papadaki HA; Mavroudi I; Almeida A; Bux J; Cichy J; Dale DC; Donadieu J; Hoglund P; Karanfilski O; Mecucci C; Palmblad J; Skokowa J; Stamatopoulos K; Touw I; Warren AJ; Welte K; Zeidler C; Dufour C
- Editorial: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2020;91(4):e12878Hoglund P
- Review: TRANSFUSION MEDICINE REVIEWS. 2019;33(4):231-235Meinke S; Karlstrom C; Hoglund P
- Editorial: TRANSFUSION. 2019;59(6):1945-1952Ryden J; Clements M; Hellstrom-Lindberg E; Hoglund P; Edgren G
- Preprint: SSRN ELECTRONIC JOURNAL. 2019Luu TT; Nguyen N-A; Ganesan S; Meinke S; Kadri N; Alici E; Höglund P
- Review: PEDIATRIC BLOOD & CANCER. 2018;65(12):e27361Palmblad J; Hoglund P
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):295Thuy TL; Vignesh S; Wagner AK; Chrobok M; Schlums H; Tornmalm J; Kadri N; Meinke S; Widengren J; Bryceson Y; Alici E; Johannsson S; Hoglund P
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):295Thuy TL; Ngoc AN; Ganesan S; Meinke S; Wagner AK; Chrobok M; Alici E; Hoglund P
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):297Ganesan S; Thuy LT; Kadri N; Meinke S; Hoglund P
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):257-258Meinke S; Brandt L; Sandgren P; Onfelt B; Hoglund P
- Letter: TRANSPLANTATION. 2017;101(5):e190-e192Sonnerborg IV; Hoglund P; Nordstrom J; Wikman A; Wennberg L; Nowak G
- Meeting abstract: BLOOD. 2016;128(22):3235Palma M; Krstic A; Berglof A; Wang Q; Blomberg E; Meinke S; Kamali-Moghaddam M; Shen Q; Jaremko G; Lundin J; Kimby E; Hoglund P; Mansson R; Osterborg A; Smith E
- Conference publication: TRANSPLANTATION. 2016;100(7):S856-S857Sonnerborg I; Hoglund P; Nordstrom J; Wennberg L; Nowak G
- Review: EXPERT REVIEW OF HEMATOLOGY. 2016;9(5):479-487Palmblad J; Nilsson CC; Hoglund P; Papadaki HA
- Review: NANOPARTICLES FOR RATIONAL VACCINE DESIGN. 2016;395:95-114Kadri N; Wagner AK; Ganesan S; Karre K; Wickstrom S; Johansson MH; Hoglund P
- Review: IMMUNOLOGICAL REVIEWS. 2015;267(1):167-177Kadri N; Thuy LT; Hoeglund P
- Conference publication: VOX SANGUINIS. 2013;105:143Sandgren PJK; Meinke S; Eckert E; Taune-Wikman A; Hoglund P
- Conference publication: IMMUNOLOGY. 2012;137:243-244Wagner AK; Tallerico R; Brauner H; Carbone E; Hoglund P; Johansson MH; Karre K
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2012;76(2):197-198Uzunel M; Hauzenberger D; Hoglund P; Wikstrom A-C
- Other: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2012;61(4):587-591Choudhury A; Höglund P; Kiessling R; Kärre K; Lundqvist A; Malmberg K; Mellstedt H; Scheynius A; Winqvist O; Osterborg A
- Conference publication: CANCER RESEARCH. 2011;71:b54Brodin P; Karre K; Hoglund P
- Review: NATURE REVIEWS IMMUNOLOGY. 2010;10(10):724-734Hoeglund P; Brodin P
- Conference publication: DIABETOLOGIA. 2010;53:S176Brauner H; Johansson S; Hall H; Flodstrom-Tullberg M; Karre K; Hoglund P
- Conference publication: VOX SANGUINIS. 2010;99:456Hoglund P; Lindquist R; Wikman A
- Book chapter: NATURAL KILLER CELLS. 2010;p. 55-64Höglund P; Ljunggren H-G
- Review: CURRENT OPINION IN IMMUNOLOGY. 2009;21(6):634-640Flodstrom-Tullberg M; Bryceson YT; Shi F-D; Hoglund P; Ljunggren H-G
- Conference publication: DIABETOLOGIA. 2009;52:S194Brauner H; Elemans M; Lemos S; Broberger C; Holmberg D; Flodstrom-Tullberg M; Karre K; Hoglund P
- Conference publication: HLA. 2009;73(5):519-520Lakshmikanth T; Burke S; Ali TH; Kimpfler S; Ursini F; Ruggeri L; Capanni M; Umansky V; Paschen A; Sucker A; Pende D; Groh V; Biassoni R; Hoglund P; Kato M; Shibuya K; Schadendorf D; Anichini A; Ferrone S; Velardi A; Karre K; Shibuya A; Carbone E; Colucci F
- Review: TRENDS IN IMMUNOLOGY. 2009;30(4):143-149Brodin P; Karre K; Hoglund P
- Corrigendum: MOLECULAR IMMUNOLOGY. 2008;45(14):3863Berglund JP; Mariotti-Ferrandiz E; Rosmaraki E; Hall H; Cazenave P-A; Six A; Hoglund P
- Conference publication: 2007 IEEE/NIH LIFE SCIENCE SYSTEMS AND APPLICATIONS WORKSHOP. 2007;:35-38Kotzer S; Salmon-Divon M; Kaplan A; Almeida CR; Hoeglund P; Davis DM; Mehr R
- Conference publication: DIABETOLOGIA. 2007;50:S190Branner H; Wareing M; Flodstrom-Tullberg M; Karre K; Hoglund P
- Conference publication: HLA. 2007;69(5):382Kaplan A; Kotzer S; Salmon-Divon M; Almeida CR; Hoglund P; Davis DM; Mehr R
- Conference publication: HLA. 2007;69(5):431-432Salmon-Divon M; Johansson S; Johansson M; Elemans M; Hoglund P; Mehr R
- Corrigendum: JOURNAL OF IMMUNOLOGY. 2006;177(8):5748Sjolin H; Robbins SH; Bessou G; Hidmark A; Tomasello E; Johansson M; Hall H; Charifi F; Hedestam GBK; Biron CA; Karre K; Hoglund P; Vivier E; Dalod M
- Review: SEMINARS IN CANCER BIOLOGY. 2006;16(5):393-403Johansson MH; Hoglund P
- Editorial: SEMINARS IN CANCER BIOLOGY. 2006;16(5):331-332Hoglund P; Klein E
- Conference publication: JOURNAL OF IMMUNOLOGY. 2006;176:S280Lundgren EK; Rosmaraki E; Berg L; Hoglund P; Winqvist O
- Review: SCIENCES STKE [ELECTRONIC RESOURCE] : SIGNAL TRANSDUCTION KNOWLEDGE ENVIRONMENT. 2006;2006(317):pe2Höglund P
- Review: NANOPARTICLES FOR RATIONAL VACCINE DESIGN. 2006;298:259-277Johansson S; Hall H; Berg L; Höglund P
- Review: TRENDS IN IMMUNOLOGY. 2005;26(11):613-618Johansson S; Berg L; Hall H; Höglund P
- Published conference paper: MOLECULAR IMMUNOLOGY. 2005;42(4):397-403Salmon-Divon M; Höglund P; Johansson MH; Johansson S; Mehr R
- Review: SEMINARS IN IMMUNOLOGY. 2003;15(6):317-324Davis DM; Igakura T; McCann FE; Carlin LM; Andersson K; Vanherberghen B; Sjöström A; Bangham CRM; Höglund P
- Review: IMMUNOLOGICAL REVIEWS. 1999;169:139-146Ji H; Korganow AS; Mangialaio S; Höglund P; André I; Lühder F; Gonzalez A; Poirot L; Benoist C; Mathis D
- Review: IMMUNOLOGICAL REVIEWS. 1997;155:11-28Hoglund P; Sundback J; OlssonAlheim MY; Johansson M; Salcedo M; Ohlen C; Ljunggren HG; Sentman CL; Karre K
- Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1995;:180WALDENSTROM M; SUNDBACK J; HOGLUND P; KARRE K
- Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1995;:97HOGLUND P; FRANKSSON L; GLAS R; KARRE K
- Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1995;:145KARRE K; SENTMAN C; HOGLUND P; JOHANSSON M; OLSSON M; WALDENSTROM M; SUNDBACK J
- Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1995;:98JOHANSSON M; BIEBERICH C; JAY G; LENDAHL U; KARRE K; HOGLUND P
- Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1994;:390HOGLUND P; FRANKSSON L; KARRE K
- Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1994;:386GLAS R; OHLEN C; HOGLUND P; KARRE K
- Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1993;:122HOGLUND P; WALDENSTROM M; KARRE K
- Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1993;:114GLAS R; HOGLUND P; OHLEN C; KARRE K
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1992;36(4):631HOGLUND P; LJUNGGREN HG
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1992;36(4):628GLAS R; FRANKSSON L; OHLEN C; HOGLUND P; KOLLER B; LJUNGGREN HG; KARRE K
- Book chapter: MODERN TRENDS IN HUMAN LEUKEMIA IX. 1992;p. 267-278Ljunggren H-G; Höglund P; Öhlén C; Kärre K
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1990;32(4):403LJUNGGREN HG; FRANKSSON L; HOGLUND P; OHLEN C; TOWNSEND A; PLOEGH HL; KARRE K
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1990;32(4):403LJUNGGREN HG; STAM N; OHLEN C; NEEFJES JJ; HOGLUND P; HEEMELS MT; BASTIN J; SCHUMACHER T; TOWNSEND A; KARRE K; PLOEGH HL
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1990;32(4):423OHLEN C; LJUNGGREN HG; HOGLUND P; KARRE K
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1990;32(4):398HOGLUND P; BIEBERICH C; GLAS R; YOSHIOKA T; JAY G; KARRE K
- Book chapter: TRANSGENIC MICE AND MUTANTS IN MHC RESEARCH. 1990;p. 282-284Höglund P; Ljunggren HG; Öhlén C; Kärre K
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1989;30(5):644OHLEN C; KLING G; HOGLUND P; HANSSON M; KARRE K
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1989;30(5):637HOGLUND P; LJUNGGREN HG; OHLEN C; KARRE K
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1987;26(3):335YAMASAKI T; LJUNGGREN HG; HOGLUND P; OHLEN C; PETERSSON M; KLEIN G; KARRE K
- Conference publication: JOURNAL OF NEURO-ONCOLOGY. 1987;5(2):187YAMASAKI T; KARRE K; LJUNGGREN HG; HOGLUND P; ANDERSSON M; PETERSSON MGE; COLLINS P; KLEIN G
- Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1986;24(4):470LJUNGGREN HG; OHLEN C; HOGLUND P; KARRE K
- Visa fler
Forskningsbidrag
- Trombocyttransfusion vid leukemi: en livräddande behandling med stor förbättringspotentialCancerfonden1 January 2025 - 31 December 2027
- Platelet function in leukemia and immune responses to platelet transfusions: clinical and experimental studiesCancerföreningen i Stockholm1 January 2025 - 31 December 2027
- Towards better transfusion management of platelet refractorinessRegion Stockholm ALF grant1 January 2024 - 31 December 2026
- Towards better transfusion management of platelet refractorinessCenter for Innovative Medicine (CIMED)1 January 2024 - 31 December 2026
- Swedish Research Council1 January 2022 - 31 December 2024
- Blodtransfusion vid leukemi: en livräddande behandling med stor förbättringspotentialCancerfonden1 January 2022 - 31 December 2024
- Platelet function in leukemia and immune responses to platelet transfusions: clinical and experimental studiesCancerföreningen i Stockholm1 January 2022 - 31 December 2024
- Swedish Heart-Lung Foundation1 January 2021 - 31 December 2021
- Towards better transfusion management of platelet refractorinessRegion Stockholm ALF grant1 January 2021 - 31 December 2023
- Towards better transfusion management of platelet refractorinessCenter for Innovative Medicine (CIMED)1 January 2021 - 31 December 2023
- Transfusion treatment of leukemia patients: predictors of transfusion outcome and immunological consequences of chronic transfusion dependence.Swedish Cancer Society1 January 2018Patients with leukemia often need transfusions with blood and platelets in order not to suffer from anemia or bleeding. Many leukemia patients are transfusion dependent already at diagnosis and even more are developing transfusion dependent as the disease progresses. Many patients also require transfusions to cope with curative treatments such as stem cell transplantation. Despite this, we know surprisingly little about what governs transfusion dependence and what factors are decisive for how individual patients respond to transfusion treatment. These issues are the focus of this project. In the first part of the project, we study stem cell mutations in leukemia patients and how they affect the frequency of transfusion with red blood cells. In this section, we are also investigating how these mutations affect the risk of developing alloantibodies to the transfused red blood cells. The second part examines how different blood donor and blood bag properties affect transfusion outcomes, and in the third part, the transfusion of platelets is studied and the question of the removal of HLA class I on the platelets makes the platelets survive better in patients with HLA antibodies. This is a highly translational project with great potential to increase understanding of what governs the transfusion pattern in leukemia patients. It aims to optimize the transfusion treatment and thus reduce the suffering of the patients. Another aim of the project is to develop new transfusion treatments for patients who do not respond to transfusions. If these are successful, it can in a very short term improve the situation for many patients who today cannot be treated optimally.
- Molecular and clinical studies of the development and function of NK cells.Swedish Cancer Society1 January 2017NK cells protect us from viral infections but also contribute to the defense against tumor emergence and tumor spread, especially in leukemia patients who have undergone stem cell transplantation or other cell therapy. We study the importance of MHC class I molecules and of the growth factor IL-15 for the development of NK cells in mice. This development process is important for the ability of NK cells to distinguish leukemia cells from normal cells. We also study NK cells and other immune cells in patients with leukemia and and patients who receive transfusion with bodily platelets to link molecular knowledge from mouse studies to treatment of people with cancer. The project aims to identify the molecular mechanisms that govern the education of NK cells in the body. The strength of the project is the genetically defined basic research models we developed over a number of years, but we also collaborate with clinics for parallel research on patients with leukemia. Such a translational approach we hope will give us clues to a deeper understanding of the biological relationships that exist between the immune system's development and its function in tumor diseases. The purpose of our research is to understand the basic relationships between how NK cells develop into the body and their ability to recognize and kill leukemia cells. The research is focused on elucidating molecular interactions both on the cell surface and within the cell. The goal is to ultimately try to utilize the knowledge to find new drugs that improve survival and quality of life in patients with leukemia and other tumor diseases.
- Molecular and clinical studies of the development and function of NK cells.Swedish Cancer Society1 January 2016NK cells protect us from viral infections but also contribute to the defense against tumor emergence and tumor spread, especially in leukemia patients who have undergone stem cell transplantation or other cell therapy. We study the importance of MHC class I molecules and of the growth factor IL-15 for the development of NK cells in mice. This development process is important for the ability of NK cells to distinguish leukemia cells from normal cells. We also study NK cells and other immune cells in patients with leukemia and and patients who receive transfusion with bodily platelets to link molecular knowledge from mouse studies to treatment of people with cancer. The project aims to identify the molecular mechanisms that govern the education of NK cells in the body. The strength of the project is the genetically defined basic research models we developed over a number of years, but we also collaborate with clinics for parallel research on patients with leukemia. Such a translational approach we hope will give us clues to a deeper understanding of the biological relationships that exist between the immune system's development and its function in tumor diseases. The purpose of our research is to understand the basic relationships between how NK cells develop into the body and their ability to recognize and kill leukemia cells. The research is focused on elucidating molecular interactions both on the cell surface and within the cell. The goal is to ultimately try to utilize the knowledge to find new drugs that improve survival and quality of life in patients with leukemia and other tumor diseases.
- Molecular and clinical studies of the development and function of NK cells.Swedish Cancer Society1 January 2015NK cells protect us from viral infections but also contribute to the defense against tumor emergence and tumor spread, especially in leukemia patients who have undergone stem cell transplantation or other cell therapy. We study the importance of MHC class I molecules and of the growth factor IL-15 for the development of NK cells in mice. This development process is important for the ability of NK cells to distinguish leukemia cells from normal cells. We also study NK cells and other immune cells in patients with leukemia and and patients who receive transfusion with bodily platelets to link molecular knowledge from mouse studies to treatment of people with cancer. The project aims to identify the molecular mechanisms that govern the education of NK cells in the body. The strength of the project is the genetically defined basic research models we developed over a number of years, but we also collaborate with clinics for parallel research on patients with leukemia. Such a translational approach we hope will give us clues to a deeper understanding of the biological relationships that exist between the immune system's development and its function in tumor diseases. The purpose of our research is to understand the basic relationships between how NK cells develop into the body and their ability to recognize and kill leukemia cells. The research is focused on elucidating molecular interactions both on the cell surface and within the cell. The goal is to ultimately try to utilize the knowledge to find new drugs that improve survival and quality of life in patients with leukemia and other tumor diseases.
- NK cells "training" and the importance of this process for how NK cells see difference between normal and tumor-converted leukemia cells in connection with stem cell transplantation and cell therapy against cancer.Swedish Cancer Society1 January 2014NK cells protect us against viral infections but also contribute to the defense against tumor emergence and tumor spread. A particularly important role has NK cells to reduce the risk of tumor recurrence in leukemia patients who have undergone stem cell transplantation or other cell therapy. A crucial role for the NK cell leukemia-killing ability plays the MHC class I molecules. We study the importance of NK cells' interactions with these molecules during NK cell development and how this affects the NK cell's ability to distinguish leukemia cells from normal cells. The project aims to identify the molecular mechanisms that govern the education of NK cells in the body. The strength of the project is the genetically defined basic research models we developed over a number of years, but we collaborate with clinics for parallel research on patients with leukemia. To better understand the biological connections, we use mathematical models and quantitative techniques derived from the field of biophysics. Such an approach we hope will give us clues to a deeper understanding of the biological relationships that exist between the immune system's development and its function in tumor diseases. The purpose of our research is to understand the basic relationships between how NK cells develop into the body and their ability to recognize and kill leukemia cells. The research is focused on elucidating molecular interactions both on the cell surface and within the cell. The goal is to ultimately try to utilize the knowledge to find new drugs that improve survival and quality of life in patients with leukemia and other tumor diseases.
- Swedish Research Council1 January 2013 - 31 December 2015
- Swedish Research Council1 January 2012 - 31 December 2016
- Creating universal donor platelets by acid stripping of HLARagnar Söderberg Foundation1 January 2012 - 31 December 2013
- Swedish Research Council1 January 2009 - 31 December 2012
- Swedish Research Council1 January 2009 - 31 December 2011
- The biology, physics, and mathematics of natural killer cell immune responsesInternational Human Frontier Science Program Organization1 May 2003 - 30 April 2006
- Visa fler
Anställningar
- Professor/Överläkare, Medicin, Huddinge, Karolinska Institutet, 2023-
- Professor/Specialistläkare, Medicin, Huddinge, Karolinska Institutet, 2016-2023
- Professor, Medicin, Huddinge, Karolinska Institutet, 2011-2016
Examina och utbildning
- Docent, Immunologi, Karolinska Institutet, 2003
- Läkarexamen, Karolinska Institutet, 1997
Uppdrag
- Prefekt, Medicin, Huddinge, Karolinska Institutet, 2021-
